Amanda Feilding is convinced of the benefits that microdosing may offer to older individuals, particularly those suffering from a neurodegenerative disorder, or undergoing palliative care.

The Beckley Foundation is currently developing several studies whose aims will be to evaluate the potential of psychedelics microdosing to enhance wellbeing and vitality and reduce cognitive decline in ageing.

These effects could be beneficial in the prevention and treatment of a number of age-related conditions.

In healthy individuals, boosting these functions may also have numerous positive effects.